The peripheral action of hexamethonium and of pentolinium

Insights

Hexamethonium and pentolinium enhanced responses to adrenaline and noradrenaline in cats. This suggests these drugs sensitize peripheral effector cells, impacting autonomic nervous system research.

Area of Science:

  • Pharmacology
  • Autonomic Nervous System
  • Neurophysiology

Background:

  • Peripheral effector cells respond to various neurotransmitters and nerve stimulation.
  • Autonomic ganglia modulate these responses.
  • Ganglionic blockers like hexamethonium and pentolinium are used to study autonomic pathways.

Purpose of the Study:

  • To investigate the effects of hexamethonium and pentolinium on peripheral effector cell responses.
  • To determine if these ganglionic blockers alter sensitivity to adrenergic agents and nerve stimulation.

Main Methods:

  • Experiments were conducted on cats.
  • Responses of limb blood vessels to adrenaline and noradrenaline were measured.
  • Responses of the nictitating membrane to adrenaline and postganglionic stimulation were assessed.
  • Effects were studied before and after administration of hexamethonium and pentolinium.

Main Results:

  • Hexamethonium and pentolinium administration increased the effects of adrenaline and noradrenaline on limb blood vessels.
  • These drugs also potentiated the actions of adrenaline and postganglionic stimulation on the nictitating membrane.
  • The observed increase in responses suggests a sensitization of peripheral effector cells.

Conclusions:

  • Hexamethonium and pentolinium can sensitize peripheral effector cells to adrenergic agonists and nerve stimulation.
  • This sensitization may play a significant role in modulating autonomic neurotransmission.
  • Findings contribute to understanding the complex interactions within the autonomic nervous system.

Related Concept Videos

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...